Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-009059
Filing Date
2021-02-09
Accepted
2021-02-09 20:01:14
Documents
1
Period of Report
2021-02-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 23252
  Complete submission text file 0001209191-21-009059.txt   24643
Mailing Address 1412 62ND STREET EMERYVILLE CA 94608
Business Address 1412 62ND STREET EMERYVILLE CA 94608 (814) 574-1546
Lucira Health, Inc. (Issuer) CIK: 0001652724 (see all company filings)

EIN.: 272491037 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1412 62ND STREET EMERYVILLE CA 94608
Business Address
Yen Tuff (Reporting) CIK: 0001832420 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39976 | Film No.: 21608676